Dr. Reddy's Laboratories, Inc. recalls
6 notices naming Dr. Reddy's Laboratories, Inc. as the recalling firm, since November 27, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Dr. Reddy's Laboratories, Inc.: Varenicline Tablets
Hazard (FDA): Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
FDAMedicines
Dr. Reddy's Laboratories, Inc.: Succinylcholine Chloride Injection
Hazard (FDA): Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
FDAMedicines
Dr. Reddy's Laboratories, Inc.: Omeprazole Delayed-release Capsules
Hazard (FDA): Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
FDAMedicines
Dr. Reddy's Laboratories, Inc.: Levetiracetam 0.75% in Sodium Chloride Injection 1
Hazard (FDA): LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam…
FDAMedicines
Dr. Reddy's Laboratories, Inc.: Javygtor
Hazard (FDA): Failed Impurities/Degradation Specifications
FDAMedicines